IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Neos Therapeutics, Inc. (“Neos” or the “Company”) (Nasdaq: NEOS) concerning possible violations of federal securities laws.
If you purchased shares of Neos and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at email@example.com.
The investigation focuses on the August 11, 2016 announcement of Neos’ financial results for the second quarter of 2016, reporting that it missed its earnings expectations by $0.49 per share. When this information was disclosed, shares of Neos fell in value.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.